We recently reported that methyl 2-(-5-fluoro-2-hydroxyphenyl)-1H-benzo[d]
imidazole-5-carboxylate (
MBIC) is a microtubule targeting agent (
MTA) with multiple mechanisms of action including apoptosis in two human
breast cancer cell-lines MCF-7 and MDA-MB-231. In the present study, investigation of early molecular events following
MBIC treatment demonstrated the induction of autophagy. This early (<24 h) response to
MBIC was characterized by accumulation of autophagy markers; LC3-II,
Beclin1, autophagic
proteins (ATGs) and collection of autophagosomes but with different variations in the two cell-lines.
MBIC-induced autophagy was associated with generation of
reactive oxygen species (ROS). In parallel, an increased activation of SAPK/JNK pathway was detected, as an intersection of ROS production and induction of autophagy. The cytotoxic effect of
MBIC was enhanced by inhibition of autophagy through blockage of SAPK/JNK signaling, suggesting that
MBIC-induced autophagy, is a possible cellular self-defense mechanism against toxicity of this agent in both
breast cancer cell-lines. The present findings suggest that inhibition of autophagy eliminates the cytoprotective activity of MDA-MB-231 and MCF-7 cells, and sensitizes both the aggressive and non-aggressive human
breast cancer cell-lines to the cytotoxic effects of
MBIC.